|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2 Pt 1
|
|
pubmed:dateCreated |
2007-1-26
|
|
pubmed:abstractText |
Advanced prostate cancer represents a heterogeneous disease entity with differences in clinical behavior, response to therapy, and survival. We assessed whether we could distinguish poor from good prognosis patients at presentation in our clinic by means of quantifying circulating cell-free mitochondrial and genomic nucleic acids in plasma.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
13
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
421-6
|
|
pubmed:meshHeading |
pubmed-meshheading:17255261-Cell Line, Tumor,
pubmed-meshheading:17255261-DNA, Mitochondrial,
pubmed-meshheading:17255261-Humans,
pubmed-meshheading:17255261-Male,
pubmed-meshheading:17255261-Mitochondria,
pubmed-meshheading:17255261-Multivariate Analysis,
pubmed-meshheading:17255261-Nucleic Acids,
pubmed-meshheading:17255261-Prognosis,
pubmed-meshheading:17255261-Proportional Hazards Models,
pubmed-meshheading:17255261-Prostatic Neoplasms,
pubmed-meshheading:17255261-Time Factors,
pubmed-meshheading:17255261-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Circulating mitochondrial nucleic acids have prognostic value for survival in patients with advanced prostate cancer.
|
|
pubmed:affiliation |
Department of Medical Oncology, University Medical Center Utrecht, 3508 GA Utrecht, the Netherlands.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
